Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

about

Perimandibular abscess associated with bisphosphonate-related osteonecrosis of the jaw.Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

P2860

Q54297796-E331F85D-B5C5-42E9-94BE-5CF613E57210 Q55394728-3B27BA57-C91E-4DB5-AA64-2BBDC0499D01

P2860

Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

Item

http://www.wikidata.org/entity/Q35803713

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@ast

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@en

type

Item

label

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@ast

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@en

prefLabel

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@ast

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@en

P1476

Effect of the cumulative dose ...... of osteonecrosis of the jaws.

@en

P2093

Berksoy Sahin

http://www.w3.org/2001/XMLSchema#string

Berna Bozkurt Duman

http://www.w3.org/2001/XMLSchema#string

Cigdem Usul Afsar

http://www.w3.org/2001/XMLSchema#string

Ismail Oguz Kara

http://www.w3.org/2001/XMLSchema#string

Meral Günaldi

http://www.w3.org/2001/XMLSchema#string

Ufuk Tatli

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonates: pharmacology, mechanisms of action and clinical uses.

Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies.

Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study

The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis.

Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.

P304

439-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275657507

http://www.w3.org/2001/XMLSchema#string

P698

26171047

http://www.w3.org/2001/XMLSchema#string

P932

4487107

http://www.w3.org/2001/XMLSchema#string

Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

about

P2860

P2860

Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932